Lucassin (terlipressin)

Lucassin is approved for the treatment of Hepatorenal Syndrome Type 1 (HRS Type 1). HRS Type 1 is a condition in which the kidneys suddenly fail to work in a person with severe liver disease. HRS Type 1 is a life-threatening complication of severe liver disease. The cause of HRS-1 is not fully understood. It is thought to be due to the kidneys drastically reducing their own blood flow, in response to large changes in blood flow in other parts of the body caused by severe liver disease. Lucassin works by improving blood flow in the kidneys. For all Lucassin enquires please contact Ikaria on (03) 9882 4855.